Multi - Award - Winning Beta-Caryophyllene
Unparalleled science and medical expertise
Our world-famous terpene blends are formulated by award-winning doctor and best-selling author, Dr. Lee Know.
Dr. Know has held positions as Scientific Evaluator, and Director of R&D for major organizations, and sat on the board of Canada's most-read natural health magazine and one of the world's most-visited natural health websites. Drawing on an extensive network of doctors, health experts, and industry professionals, our products go through rigorous testing and scientific validation for years before ever reaching your hands.
This is why Cannanda is the #1 terpene brand recommended by doctors, chiropractors, massage therapists, pharmacists, osteopaths, psychotherapists, and veterinarians.
Let customers speak for us
Quality You Can Trust
featured in
Blog posts
Glucosamine and Dementia: Why CB2 Oil Is Best for Joint Pain Relief
You take glucosamine to look after your knees. You never thought it could matter to your brain. Then this headline pops up: "Common Joint Supplement Linked to 25% Higher Dementia Risk." That's scary. So let's discuss what the study found, and why CB2 oil is worth a look if you want joint comfort without that question mark.
BCP for Liver Health: How It Compares to Milk Thistle & NAC
How BCP Absorbs Through Skin for Real Topical Relief
Press Releases
FrontrowMD Clinicians Choose Cannanda CB2 Brand of Beta-Caryophyllene
Cannanda has joined FrontrowMD. Hundreds of independent clinicians now share Cannanda CB2 products with their patients, with no compensation involved. This gives shoppers a real, verifiable way to see that medical professionals trust the brand.
Cannanda Launches Ongoing Support Plan for CB2 Oils
Cannanda Launches CB2 Cool: The World’s Leading Beta-Caryophyllene Brand Expands with a Breakthrough Stress Relief Oil
Cannanda, the global leader in beta-caryophyllene (BCP) innovation and the world’s top-selling brand of CB2 oils, proudly announces the launch of its newest product: Cannanda CB2 Cool.
















































































































